Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55.8Revenue $M0.1Net Margin (%)-6,155.5Z-Score2.1
Enterprise Value $M31.5EPS $-1.8Operating Margin %-6,113.2F-Score4
P/E(ttm))0Cash Flow Per Share $-7.8Pre-tax Margin (%)-6,155.5Higher ROA y-yY
Price/Book2.110-y EBITDA Growth Rate %-8.4Quick Ratio15.2Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-53.8Current Ratio15.2Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-46.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-59.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M31.0ROI % (ttm)-62.0Gross Margin Increase y-yN

Gurus Latest Trades with APPY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

APPY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


APPY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hurd Donald RSVP & Chief Commercial Officer 2014-04-14Buy35,000$2.04-11.76view
Hurd Donald RSVP, Chief Commerical Officer 2012-09-21Buy15,000$1.99-9.55view
SCHOETTLER GAILDirector 2012-08-03Buy2,500$1.5813.92view
Lundy StevePresident, CEO 2012-06-29Buy4,000$1.93-6.74view
PUSEY GREGORYVice President 2012-06-29Buy2,000$1.94-7.22view
Merson Michael RDirector 2012-06-29Buy1,000$1.92-6.25view
MCGONEGAL JEFFREYCFO 2012-06-28Buy5,000$1.92-6.25view
Colgin MarkChief Scientific Officer 2009-02-10Sell0$0-6.25view
Merson Michael RDirector 2008-07-01Sell0$0-6.25view

Press Releases about APPY :

    Quarterly/Annual Reports about APPY:

    News about APPY:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD Jul 09 2012 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2010 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Weekly CFO Buys Highlight: AspenBio Pharma, Solarwinds, Affymetrix, Cascade Financial Corp., Bank of Jul 31 2010 
    advise??? Apr 28 2010 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Nov 05 2009 
    AspenBio Pharma Inc. Reports Operating Results (10-Q) Aug 07 2009 
    AspenBio Pharma Inc. (APPY) CEO Daryl Faulkner buys 10,000 Shares May 21 2009 
    AspenBio Pharma Inc. (APPY) COO & Chief Medical Officer Robert Frederick Caspari buys 3,200 Shares May 19 2009 

    More From Other Websites
    VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 08 2014
    Venaxis Files Response to FDA's Request for Additional Information Dec 03 2014
    VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 03 2014
    Venaxis, Inc. (APPY) in Focus: Stock Adds 7.6% in Session Nov 26 2014
    VENAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 20 2014
    VENAXIS, INC. Financials Nov 19 2014
    Venaxis to Present at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum Nov 13 2014
    10-Q for Venaxis, Inc. Nov 12 2014
    VENAXIS, INC. Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Venaxis’ APPY1 Test Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 Oct 27 2014
    Venaxis' APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14 Oct 27 2014
    Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14 Oct 14 2014
    Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14 Oct 14 2014
    Venaxis to Present at September Investor Conferences Aug 28 2014
    VENAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 14 2014
    VENAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 11 2014
    VENAXIS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Venaxis Announces Regulatory and Market Development Progress Aug 11 2014
    Venaxis to Provide Business Update, including FDA Submission Update Aug 07 2014
    Venaxis to Present at Canaccord Genuity 34th Annual Growth Conference Aug 05 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK